Navigation Links
Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market
Date:7/22/2008

MINNEAPOLIS, July 22 /PRNewswire/ -- Nonin Medical, a leading innovator of physiological monitoring solutions for more than 20 years, has entered the clinical testing phase with its breakthrough technology to measure regional oxygen saturation. Today's most common application for this technology is the continuous monitoring of the regional blood oxygenation in the brain -- cerebral oximetry.

Early testing data and outcomes from an ongoing clinical study at the Duke University Medical Center have yielded favorable results. These data results support the objective to simplify sensor application while improving the usefulness of the measurement.

For over two decades, Nonin Medical has remained at the forefront of noninvasive physiological monitoring with specific focus on highly effective signal processing and the advancement of innovative pulse oximeter products. With the introduction of the Onyx(R), the world's first fingertip pulse oximeter, Nonin Medical changed the global market for oximetry. Today, Nonin Medical has the largest installed base of pulse oximeters in the industry with well over one million units worldwide.

"This invaluable clinical and technical experience combined with a vision for the future has enabled us to develop a product that promises to advance the field of patient monitoring, once again," said Gary Tschautscher, CEO and President of Nonin Medical. "We understand the immense pressure on the healthcare market to reduce the cost of patient care while providing new, more effective, yet simple solutions. Our newly developed sensor and patented signal processing technology is designed to deliver on these objectives."

The advanced modular design of this new technology permits future expansion of functionality, while also permitting product and data integration into other monitoring systems. This clearly aligns with Nonin Medical's vision for interoperability and facilitating information flow without the need of
'/>"/>

SOURCE Nonin Medical
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
2. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
3. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
4. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
5. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
6. Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms
7. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
8. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
9. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
10. Oridion Announces Major Medical Research and Congress Presentations
11. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2015)... , Aug. 3, 2015  Lexicon Pharmaceuticals, Inc. ... pivotal TELESTAR Phase 3 clinical trial met its ... etiprate in treating cancer patients with carcinoid syndrome ... standard of care. Telotristat etiprate was discovered using ... and is the company,s first discovery to complete ...
(Date:7/31/2015)... , July 31, 2015  Seeger Weiss LLP is ... (FDA) issued a warning letter to C.R. Bard, the manufacturer ... taking adequate strides to correct violations the agency found at ... these violations after the FDA cited them during Inspectional Observations ... in Bard,s Tempe, AZ , location and ...
(Date:7/31/2015)... July 31, 2015 RnRMarketResearch.com ... market research report that provides an overview of ... data sourced from in-house databases, secondary and primary ... needles market products pipeline spread across 124 pages, ... 73 tables and 5 figures is now available ...
Breaking Medicine Technology:Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article from The ... Found to Release Natural Painkiller That Can Last 'For Five Weeks'" discusses the ... report, the new study showed that harvesting stem cell-rich bone marrow from the hip, ...
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science (IHS) has ... , The acquisition includes all of IBAM NA’s cyclotron sites and research and development ... robust regionally located business, as well as a large manufacturing hub in Noblesville, Indiana,” ...
(Date:8/3/2015)... Ramon, CA (PRWEB) , ... August 03, 2015 ... ... leading global insurance brokerage firm, announced today that Joe Williams has joined its ... development, sales, and delivering HUB's differentiated service model to his clients. Mr. Williams ...
(Date:8/3/2015)... Portland, Ore. (PRWEB) , ... August 03, 2015 ... ... President of Government Programs, with accountability for overall performance of the company’s Medicare ... a key focus of Cambia’s strategy to deliver better health for members. In ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... leading provider of medical information, risk management and investigative services, has introduced ... direction toward focused, expert information solutions that improve business outcomes for its ...
Breaking Medicine News(10 mins):Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
... Today, in light of a,recent study released by ... April is National STD Awareness Month, Congresswoman Stephanie ... introduced a bi-partisan,resolution urging the House of Representatives ... prevention, screening and treatment of,sexually transmitted diseases (STD)., ...
... Healthcare Realty,Trust Incorporated (NYSE: HR ) today announced ... closes, it will report results for the first,quarter of ... Central Time, Healthcare Realty Trust will,hold a conference call ... Company and industry trends. Simultaneously with,the conference call, a ...
... Awardee to be named at 6th International Stem Cell Symposium Seoul, Korea ... ... SEOUL, Korea, April 22 AlphaMed Press,publisher of the peer-reviewed journal STEM ... the,International Stem Cell Symposium, will be presented on June 20, 2008 in,Seoul, ...
... But doctors want more data, and device not yet approved ... -- A new kind of drug-coated stent was better at ... large-scale U.S. study of the device, researchers report. , "This ... the Xience stent is superior to the Taxus stent, in ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... treatment of peripheral vascular disease,explains interruption of its ... p.m. PT/5:00 p.m./ET. As a result of teleconference,vendor ... as planned., Interested parties are encouraged to ...
... parent of a sick child is,emotionally and physically draining. ... a world where there is very little,control and every ... (See video from CIGNA Healthcare at:, http://media.medialink.com/WebNR.aspx?story=34951 ... Leukemia Foundation called the,"Hope Binder" helps parents manage the ...
Cached Medicine News:Health News:Tubbs Jones Introduces Resolution Encouraging STD Prevention 2Health News:Healthcare Realty Trust Announces First Quarter Earnings Release Date and Conference Call 2Health News:Stem Cells(R) and International Stem Cell Symposium Present Annual Stem Cells(R) Young Investigator Award 2Health News:New Drug-Coated Stent Does Well in Early Trial 2Health News:New Drug-Coated Stent Does Well in Early Trial 3
... Sterile E*Kits® can be a valuable ... care; when the items necessary for a ... facility protocols and continuum of care are ... are packaged in sequence of use, allowing ...
... to dry trays to specialty vaginal & ... Health offers the widest offering in patient ... that are proven to be safe and ... surgical site infections. Cardinal Health Scrub Care ...
The applicator is designed for a smooth delivery of the solution for surgical procedures....
... The Anti-HTLV Mixed Titer Performance Panel ... from weak to strong positive for antibodies ... is intended for use by manufacturers and ... assays. Comprehensive data from all major test ...
Medicine Products: